Spruson & Ferguson has an established practice in the biotechnology, pharmaceutical and life sciences industries.

Our patent attorneys are technically qualified in areas including genetics, biophysics, molecular biology, microbiology, biomedical engineering, chemistry and biochemistry with the majority qualified to PhD level.

With our strong network of offices across the Asia-Pacific, we are well placed to assist clients with their patent portfolios in this rapidly expanding industry.

Key Team Members View More
Sydney, Australia
Download Vcard View Profile
Dr Simon Potter
Managing Director | Australia
Patents: Chemical & Life Science
+61 2 9393 0100 simon.potter@spruson.com
Simon is an accomplished professional services leader, and commenced as Managing Director of Spruson & Ferguson Australia following key leadership positions as head of the Australian Chemical/Life Sciences team…
Simon is an accomplished professional services leader, and commenced as Managing Director of Spruson & Ferguson Australia following key…
Read More
Singapore, Singapore
Download Vcard View Profile
Choo Chiou Yu
Principal, Director Singapore, Chemical Practice Group Leader Asia
Patents: Chemical & Life Science
+65 6333 7200 chiouyu.choo@spruson.com
Chiou Yu is Head of the Chemical team in Asia and is a registered Singapore patent attorney. Chiou Yu has extensive experience in patent practice in Asia and assists…
Chiou Yu is Head of the Chemical team in Asia and is a registered Singapore patent attorney. Chiou Yu…
Read More
Sydney, Australia
Download Vcard View Profile
Katrina Crooks
Principal, Head of Spruson & Ferguson Lawyers
Spruson & Ferguson Lawyers: Litigation
+61 2 9393 0300 katrina.crooks@spruson.com
Katrina is counted amongst Australia’s top IP litigation lawyers, with 25 years’ experience of obtaining successful outcomes for clients. Dual qualified as a lawyer and patent attorney, patent litigation is…
Katrina is counted amongst Australia’s top IP litigation lawyers, with 25 years’ experience of obtaining successful outcomes for clients. Dual…
Read More
Latest News & Insights
Sanofi v Amgen dispute: Australian update
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners around the world. The patent litigation concerning Amgen’s PCSK9 antibody…
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners…
Read More
Skinny labelling in the Australian context: an overview
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be protected by several different patent claim formats, including method of…
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be…
Read More
Pharmaceutical patent term extension in Australia
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial importance, and in recent years have become of particular interest…
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial…
Read More
View All

Contact our Expert Team

Contact Us
Contact Us